Ethnic and dose-dependent differences in atropine efficacy for myopia control: a systematic review and meta-analysis

医学 阿托品 民族 眼科 梅德林 儿科 眼病 验光服务 民族血统 折射误差 视力障碍 横断面研究 青光眼 物理疗法
作者
Sayantan Biswas,Carla Lança,Daisy Kynman-Sprinks,Andrzej Grzybowski
出处
期刊:British Journal of Ophthalmology [BMJ]
卷期号:110 (5): 483-491 被引量:1
标识
DOI:10.1136/bjo-2025-328518
摘要

BACKGROUND/AIM: Clinical uncertainty remains regarding optimal atropine concentration, treatment duration and potential differences in efficacy for myopia control between Asian and non-Asian children. This systematic review and meta-analysis evaluated the efficacy of different concentrations of atropine for myopia control, comparing outcomes among East Asian, South Asian and white European children. METHODS: Five databases were searched for randomised controlled trials (RCTs) including children ≤16 years with myopia who received atropine treatment. Thirty-four RCTs with ≥12 months of follow-up were included. Weighted mean differences (WMD) in spherical equivalent refraction (SER) progression and axial length (AL) elongation were pooled by atropine concentration and ethnicity. RESULTS: Compared with controls, atropine significantly reduced myopia progression across all concentrations: <0.1% (WMD in SER: 0.44 (95% CI 0.35 to 0.52) dioptres (D)/year; AL: -0.20 (95% CI -0.24 to -0.16) mm/year), 0.1% to <0.5% (0.81 (95% CI 0.50 to 1.13) D/year) and ≥0.5% (1.06 (95% CI 0.88 to 1.24) D/year; -0.36 (95% CI -0.40 to -0.33) mm/year). The pooled effect on SER and AL progression across all concentrations was greater in East Asians (0.63 (95% CI 0.50 to 0.76) D/year; -0.26 (95% CI -0.31 to -0.20) mm/year) than in South Asians (0.40 (95% CI 0.11 to 0.70) D/year; -0.13 (95% CI -0.21 to -0.05) mm/year) or white Europeans (0.18 (95% CI 0.11 to 0.25) D/year; -0.11 (95% CI -0.16 to -0.05) mm/year). CONCLUSION: Atropine slows myopia progression in a dose-dependent manner in studies with 1-5 years of follow-up. Efficacy appears greater in Asian children, particularly East Asians, who also exhibit greater photopic pupil dilation. These findings support the role of atropine in myopia control and highlight the importance of ethnicity-specific considerations when prescribing and tailoring treatment strategies. PROSPERO REGISTRATION NUMBER: CRD42023454104.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage的应助被Adler采纳,获得10
1秒前
1秒前
Neko发布了新的文献求助30
1秒前
天真的雨完成签到,获得积分10
3秒前
3秒前
姜雪莲完成签到,获得积分10
4秒前
SML发布了新的文献求助10
4秒前
ranqiang完成签到,获得积分20
5秒前
去内蒙的小企鹅完成签到 ,获得积分10
5秒前
香蕉觅云的应助被小羊哥采纳,获得10
5秒前
彭于晏的应助被Homura采纳,获得10
5秒前
CodeCraft的应助被活泼的厅厅采纳,获得30
6秒前
KK发布了新的文献求助10
6秒前
上天777完成签到,获得积分10
7秒前
aajhajkahna举报11M的求助涉嫌违规
9秒前
赘婿的应助被snowman采纳,获得10
11秒前
haibinxiao发布了新的文献求助30
12秒前
12秒前
13秒前
今后的应助被zyk采纳,获得10
14秒前
自由秋完成签到,获得积分10
14秒前
慕暖完成签到 ,获得积分10
16秒前
17秒前
17秒前
zhq发布了新的文献求助10
17秒前
17秒前
郭磊发布了新的文献求助10
18秒前
18秒前
18秒前
19秒前
19秒前
赘婿的应助被Eina采纳,获得10
21秒前
研友_LMgz0Z发布了新的文献求助10
21秒前
余念安完成签到,获得积分10
21秒前
21秒前
oymh完成签到 ,获得积分10
21秒前
科研通AI6.4的应助被云晓采纳,获得30
21秒前
yu完成签到,获得积分10
23秒前
司空铭发布了新的文献求助10
24秒前
cyx完成签到 ,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
自動車の空力技術 800
Organizational Behavior 510
Management and the Arts 510
Geschichtliche Grundbegriffe (GGB), Band 5: Pro–Soz 300
Die Religion in Geschichte und Gegenwart (RGG), 4. Auflage, Band 7: R–S 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7790913
求助须知:如何正确求助?哪些是违规求助? 9328420
关于积分的说明 20422617
捐赠科研通 7380493
什么是DOI,文献DOI怎么找? 3323238
关于科研通互助平台的介绍 2471056
邀请新用户注册赠送积分活动 2340117